222. Cryptococcus in 2017: Bench to Bedside
Saturday, October 7, 2017: 10:30 AM-12:00 PM
Room: 15AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the therapeutic challenges of managing patients with cryptococcosis
  • develop strategies to improve the outcomes of patients with cryptococcosis
  • identify virulence determinants of Cryptococcus neoformans
  • describe how the host responds to Cryptococcus neoformans
  • explain the dynamic between cryptococcal virulence factors and host responses

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Pharmacists, Researchers, Scientists

Tracks: Trainee, Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Adult ID

Moderators:  Joshua Nosanchuk, MD, Albert Einstein College of Medicine and Tihana Bicanic, MD, St George's University of London

10:30 AM
An Overview of Host Defense Against Cryptococcus
Liise-Anne Pirofski, MD, FIDSA

10:55 AM
11:45 AM

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-308-L01-P


J. Nosanchuk, None

T. Bicanic, Gilead Sciences: Speaker at sponsored educational meeting , Speaker honorarium

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.